Diagnostic Company LumiraDX Goes Public In $5Bn SPAC Merger
LumiraDX secured $400m in new debt financing and will use all proceeds to fund growth.
You may also be interested in...
The SPAC deal between CM Life Sciences II and SomaLogic is valued at $1.25bn.
As the SPAC boom continues, innovative medtechs are expected to become acquisition targets.
AI voice tech start-up Canary Speech is developing algorithmic models for detecting behavioral health, progressive neurological and cognitive diseases based on a 40-second recording of speech. Medtech Insight caught up with Canary CEO Henry O’Connell at DHIS West to learn more about the company and its plans.